Two cases of Allgrove syndrome with mutations in the AAAS gene.

Allgrove syndrome is a rare autosomal recessive disorder characterized by the triad of adrenal insufficiency, achalasia and alacrima. This syndrome, also known as triple A syndrome, is now known to be caused by mutations in the AAAS gene. In the present study, we report two new patients of Allgrove syndrome with mutations in the AAAS gene. Patient 1 was a 22-year-old Japanese woman, born to consanguineous parents. She was confirmed to have adrenal insufficiency at the age of 3 years and 6 months. She developed alacrima and bilateral optic nerve atrophy at the age of 8 years. She had been noticed to have dysphagia. Based on these findings, she was diagnosed as having Allgrove syndrome. Mutation analysis revealed a novel homozygous point mutation in exon 7 of her AAAS gene, changing codon 194 encoding Arg (CGA) to a stop codon (TGA) (R194X). Patient 2 was a 7-year-old Japanese boy, born to consanguineous parents. At the age of 1 year, he was noticed to be unable to produce tears. He was confirmed to have adrenal insufficiency, mental retardation and spastic diplegia at the age of 5 years and 4 months. He was tentatively diagnosed as having Allgrove syndrome, although he has never complained of dysphasia. Mutation analysis revealed a homozygous point mutation in exon 4 of his AAAS gene, changing codon 119 encoding Arg (CGA) to a stop codon (TGA) (R119X). Both of the R119X and R194X mutations are predicted to result in truncated and non-functioning ALADIN proteins, and thus the diagnosis of Allgrove syndrome was confirmed by the mutation analyses. These findings indicate that there exist significant clinical variability and mutational heterogeneities in Japanese patients with this syndrome.

[1]  J. Cronshaw,et al.  The nuclear pore complex protein ALADIN is mislocalized in triple A syndrome , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Huebner,et al.  Triple A syndrome: genotype–phenotype assessment , 2003, Clinical genetics.

[3]  M. Prevett,et al.  Allgrove or 4 “A” syndrome: an autosomal recessive syndrome causing multisystem neurological disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[4]  S. Gollin,et al.  Chromosomal fragility in patients with triple A syndrome , 2003, American journal of medical genetics. Part A.

[5]  Nicholas W Wood,et al.  Clinical and genetic characterisation of families with triple a (Allgrove) syndrome , 2002 .

[6]  Toshiaki Tanaka,et al.  Analysis of the AAAS gene in a Japanese patient with triple A syndrome. , 2002, Endocrine journal.

[7]  A. Huebner,et al.  Clinical and Novel Molecular Findings in a 6.8-Year-Old Turkish Boy with Triple A Syndrome , 2002, Hormone Research in Paediatrics.

[8]  C. Stratakis,et al.  Spectrum of mutations of the AAAS gene in Allgrove syndrome: lack of mutations in six kindreds with isolated resistance to corticotropin. , 2001, The Journal of clinical endocrinology and metabolism.

[9]  S. Hennig,et al.  Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. , 2001, Human molecular genetics.

[10]  Claude Mugnier,et al.  Mutant WD-repeat protein in triple-A syndrome , 2000, Nature Genetics.

[11]  Temple F. Smith,et al.  The WD repeat: a common architecture for diverse functions. , 1999, Trends in biochemical sciences.

[12]  A. Clark,et al.  ACTH resistance syndromes. , 1999, Journal of pediatric endocrinology & metabolism : JPEM.

[13]  M. Murata Japanese Specific Bone Age Standard on the TW2 , 1993 .

[14]  G. Clayden,et al.  FAMILIAL GLUCOCORTICOID DEFICIENCY WITH ACHALASIA OF THE CARDIA AND DEFICIENT TEAR PRODUCTION , 1978, The Lancet.